SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-23-016029
Filing Date
2023-05-30
Accepted
2023-05-30 08:30:12
Documents
15
Period of Report
2023-05-30
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K dmtp20230529_8k.htm   iXBRL 8-K 34814
2 EXHIBIT 99.1 ex_527214.htm EX-99.1 15698
7 logo.jpg GRAPHIC 12843
  Complete submission text file 0001437749-23-016029.txt   209761

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA dmac-20230530.xsd EX-101.SCH 3602
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE dmac-20230530_def.xml EX-101.DEF 11518
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE dmac-20230530_lab.xml EX-101.LAB 15385
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE dmac-20230530_pre.xml EX-101.PRE 11674
9 EXTRACTED XBRL INSTANCE DOCUMENT dmtp20230529_8k_htm.xml XML 2561
Mailing Address 301 CARLSON PARKWAY SUITE 210 MINNEAPOLIS MN 55305
Business Address 301 CARLSON PARKWAY SUITE 210 MINNEAPOLIS MN 55305 (763) 496-5454
DiaMedica Therapeutics Inc. (Filer) CIK: 0001401040 (see all company filings)

IRS No.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36291 | Film No.: 23971567
SIC: 2834 Pharmaceutical Preparations